Discover TRODELVY® (sacituzumab govitecan-hziy) treatment guidance, clinical trial results, side effects, and patient support services. See Important Facts & Important Warning.

Dec 10, 2025 · What is Trodelvy? Trodelvy (sacituzumab govitecan-hziy) is a targeted chemotherapy used to treat metastatic triple-negative breast cancer (mTNBC) and HR+/HER2 …

Dec 23, 2025 · Trodelvy is used to treat some HER2-negative breast cancers. Trodelvy (chemical name: sacituzumab govitecan-hziy) is a targeted therapy medication called an antibody-drug …

TRODELVY contains a genotoxic component, SN-38, and targets rapidly dividing cells. Advise pregnant women and females of reproductive potential of the potential risk to a fetus.

May 14, 2025 · Trodelvy (sacituzumab govitecan-hziy) is a prescription infusion that treats certain forms of breast cancer in adults. Learn about dosage, side effects, and more.

Trodelvy is for adults with triple-negative breast cancer (TNBC) or hormone receptor (HR)-positive, HER2-negative breast cancer (HR+/HER2-) that has spread in the body or cannot be …

TRODELVY is indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) who have received two or more prior …

Dec 16, 2024 · Trodelvy (sacituzumab govitecan-hziy) is a brand name prescription that’s used for certain types of cancers. Learn about cost, how it works, dosage, and more.

Adverse reaction leading to a dose reduction of TRODELVY occurred in 33% of patients. The most frequent (> 5%) adverse reaction leading to dose reduction were neutropenia (16%) and …

TRODELVY is designed to bind to cells with Trop-2 and deliver powerful anticancer medicine. Information from laboratory studies suggests that this is how TRODELVY works.